POC1A promotes malignant phenotypes in non-triple-negative breast cancer cell models with EMT- and Wnt/β-catenin-related alterations - Scorecard - MDSpire
Advertisement
POC1A promotes malignant phenotypes in non-triple-negative breast cancer cell models with EMT- and Wnt/β-catenin-related alterations
Clinical Scorecard: POC1A Enhances Malignant Characteristics in Non-Triple-Negative Breast Cancer Cell Lines Through EMT and Wnt/β-Catenin Pathway Modifications
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Care Setting
Clarify or source this statement.
Key Highlights
remove
Guideline-Based Recommendations
Diagnosis
Management
R
e
m
o
v
e
o
r
s
o
u
r
c
e
t
h
e
r
e
c
o
m
m
e
n
d
a
t
i
o
n
r
e
g
a
r
d
i
n
g
P
O
C
1
A
a
s
a
t
h
e
r
a
p
e
u
t
i
c
t
a
r
g
e
t
.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients diagnosed with non-triple-negative breast cancer
POC1A may serve as a candidate molecular marker for targeted therapies.
